Adam R Craig's Net Worth
$4.64 Million
Who is Adam R Craig?
Adam R Craig has an estimated net worth of $4.64 Million. This is based on reported shares across multiple companies, which include Innovive Pharmaceuticals, Inc., CTI BIOPHARMA CORP, and SUNESIS PHARMACEUTICALS INC.
SEC CIK
Adam R Craig's CIK is 0001339498
Past Insider Trading and Trends
2022 was Adam R Craig's most active year for acquiring shares with 17 total transactions. Adam R Craig's most active month to acquire stocks was the month of November. 2022 was Adam R Craig's most active year for disposing of shares, totalling 37 transactions. Adam R Craig's most active month to dispose stocks was the month of May. 2022 saw Adam R Craig paying a total of $603,733.23 for 1,787,708 shares, this is the most they've acquired in one year. In 2022 Adam R Craig cashed out on 1,392,115 shares for a total of $4,067,059.14, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Innovive Pharmaceuticals, Inc. No price found
VP and Chief Medical Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 10
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 29
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
CTI BIOPHARMA CORP No price found
President and CEO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -31.47K |
$9.10 | -$286,377.00 |
0
|
Jun 26
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 14
| |||
Form 4
|
—
|
0
|
$3.42 | -$440,163.04 | 29.44K |
Scheduled
|
Jan 24
| ||
Form 4
| +5.67% | 1.58K |
$3.46 | -$589,388.60 | 29.44K |
Scheduled
|
Dec 29 - Jan 3
| ||
Form 4
|
—
|
0
|
$3.42 | -$1,250,961.35 | 27.86K |
Scheduled
|
Nov 9 - Nov 10
| ||
Form 4
|
—
|
0
|
$3.64 | -$1,354,190.47 | 27.86K |
Scheduled
|
Sep 12
| ||
Form 4
| +21.87% | 5K |
$5.50 | $27,500.00 | 27.86K |
Aug 16
| |||
Form 4
| +37.07% | 6.18K |
$3.49 | -$361,509.45 | 22.86K |
Scheduled
|
Jun 30 - Jul 6
| ||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Jun 1 - Jun 3
| |||
Form 4
|
—
|
0
|
$3.42 | -$372,773.46 | 16.68K |
Scheduled
|
Jun 1 - Jun 3
| ||
Form 4
| +23.54% | 3.18K |
$2.11 | $6,699.22 | 16.68K |
Dec 31 - Mar 9
| |||
Form 4
| +170.00% | 8.5K |
$1.88 | $15,962.37 | 13.5K |
Jun 30 - Dec 2
| |||
Form 4
|
∞
| 5K |
$0.98 | $4,900.00 | 5K |
Jul 1 - Mar 10
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 29
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 20
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
SUNESIS PHARMACEUTICALS INC (VIRX) Snapshot price: $0.2301
EVP, Development & CMO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +84.33% | 10.73K |
$2.22 | -$18,430.44 | 23.45K |
Feb 27
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 31
| |||
Form 4
| -16.72% | -2.55K |
$8.00 | -$20,432.00 | 12.72K |
Scheduled
|
Aug 27
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 28
| |||
Form 4
| +295.26% | 7.66K |
—
|
—
| 10.26K |
Feb 28
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 29
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||